NFKB1 and neoplasm: Similarly, CRIP2 inhibits tumor progression and angiogenesis by inhibiting NF-κB-mediated transcription of pro-angiogenic cytokines IL-6, IL-8, and vascular endothelial growth factor [71], providing important evidence that CRIP2 acts as a tumor suppressor.